Does Comorbid Anxiety or Depression Moderate Effects of Approach Bias Modification in the Treatment of Alcohol Use Disorders?

被引:20
|
作者
Salemink, Elske [1 ]
Rinck, Mike [2 ,3 ]
Becker, Eni [2 ]
Wiers, Reinout W. [4 ]
Lindenmeyer, Johannes [5 ]
机构
[1] Univ Utrecht, Dept Clin Psychol, Expt Psychopathol EPP Lab, POB 80140, NL-3508 TC Utrecht, Netherlands
[2] Radboud Univ Nijmegen, Behav Sci Inst, Dept Clin Psychol, Nijmegen, Netherlands
[3] Ruhr Univ, Dept Clin Psychol & Psychotherapy, Bochum, Germany
[4] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol Adapt Lab, ABC & Yield Res Prior Areas, Amsterdam, Netherlands
[5] Lindow & Med Sch, Salus Clin, Brandenburg, Germany
关键词
approach bias modification; alcohol dependence; comorbid anxiety disorder; comorbid major depressive disorder; relapse prevention; IDENTIFICATION TEST AUDIT; ACTION-TENDENCIES; SUBSTANCE USE; DEPENDENCE; RELIABILITY; PREVALENCE; ADDICTION; VALIDITY;
D O I
10.1037/adb0000642
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Approach bias modification (ApBM) is a promising new add-on training intervention for patients with alcohol use disorder (AUD). Given that comorbid anxiety and major depressive disorders are very common in AUD, and that such comorbidity affects psychological treatments negatively, the primary aim of the present study was investigating whether ApBM training is moderated by anxiety/major depressive disorder comorbidity. The secondary aim was to examine whether ApBM's relapse-preventive effect can be replicated. Method: We conducted a large-scale randomized controlled trial (RCT) in a clinical sample of AUD inpatients (n = 729) with a follow-up assessment after 1 year. All patients received 12 weeks of inpatient treatment as usual (TAU). On top of that, patients were randomized to a 12-session ApBM (TAU + ApBM), and a no-training control condition (TAU-only). Treatment success was defined as either no relapse or a single lapse shorter than 3 days in duration, ended by the patient and followed by at least 4 weeks of abstinence. Failure was defined as relapse, passed away, no contact, or refusal to provide information. Results: We found that TAU + ApBM had significantly higher success rates than TAU-only at 1-year follow-up. Importantly, anxiety/depressive comorbidity moderated ApBM's effects: Adding ApBM to TAU increased success rates more for patients with a comorbid anxiety and/or depressive disorder than for patients without such comorbidity. Conclusions: Our data suggest that adding ApBM to TAU works better in patients with a comorbid anxiety and/or depressive disorder; a promising finding gave the high rates of comorbidity in clinical practice. Public Health Significance Statement This study indicates that patients with an alcohol use disorder (AUD) who received standard care plus training to avoid alcohol cues had less relapse into drinking about a year later compared to patients who only received standard care. This study indicates that among patients with an AUD, it is particularly those who have an additional anxiety or major depressive disorder, who benefit from the alcohol-avoid training.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 50 条
  • [41] Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders
    Melchior, Maria
    Prokofyeva, Elena
    Younes, Nadia
    Surkan, Pamela J.
    Martins, Silvia S.
    [J]. BMC PSYCHIATRY, 2014, 14
  • [42] Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders
    Maria Melchior
    Elena Prokofyeva
    Nadia Younès
    Pamela J Surkan
    Silvia S Martins
    [J]. BMC Psychiatry, 14
  • [43] Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders
    Wilens, Timothy E.
    Adler, Lenard A.
    Weiss, Margaret D.
    Michelson, David
    Ramsey, Janet L.
    Moore, Rodney J.
    Renard, Didier
    Brady, Kathleen T.
    Trzepacz, Paula T.
    Schuh, Leslie M.
    Ahrbecker, Lisa M.
    Levine, Louise R.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2008, 96 (1-2) : 145 - 154
  • [44] Treatment response of depressive patients with comorbid alcohol use disorders
    Ishikawa, Hiromi
    [J]. ASIA-PACIFIC PSYCHIATRY, 2012, 4 : 192 - 192
  • [45] TREATMENT RESPONSE OF DEPRESSIVE PATIENTS WITH COMORBID ALCOHOL USE DISORDERS
    Ishikawa, H.
    Shirasaka, T.
    Hashimoto, E.
    Saito, T.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 133A - 133A
  • [46] TREATMENT RESPONSE OF DEPRESSIVE PATIENTS WITH COMORBID ALCOHOL USE DISORDERS
    Tayama, M.
    Hashimoto, E.
    Saito, T.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 57A - 57A
  • [47] Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide
    Pini, S
    Amador, XF
    Dell'Osso, L
    Rossi, NB
    Cassano, P
    Savino, M
    Cassano, GB
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (01) : 15 - 21
  • [48] Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders
    Clarke, Eleanor
    Clarke, Patrick
    Gill, Shane
    Paterson, Tom
    Hahn, Lisa
    Galletly, Cherrie
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2019, 252 : 435 - 439
  • [49] Comorbid depression and treatment of anxiety disorders, OCD, and PTSD: Diagnosis versus severity
    Breteler, J. Klein
    Ikani, N.
    Becker, E. S.
    Spijker, J.
    Hendriks, G.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2021, 295 : 1005 - 1011
  • [50] DEPRESSION, ALCOHOL USE DISORDERS AND SUBSTANCE USE DISORDERS MODERATE THE IMPULSIVITY LEVELS OF COLLEGE STUDENTS
    Rosen, R.
    Sisante, J.
    Jiantonio-Kelly, R.
    Dager, A.
    Raskin, S.
    Tennen, H.
    Austad, C.
    Fallahi, C.
    Wood, R.
    Pearlson, G.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 58A - 58A